1. Home
  2. POAS vs ICCM Comparison

POAS vs ICCM Comparison

Compare POAS & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

POAS

Phaos Technology Holdings (Cayman) Limited Class A Ordinary Shares

N/A

Current Price

$1.69

Market Cap

23.6M

Sector

Industrials

ML Signal

N/A

Logo IceCure Medical Ltd.

ICCM

IceCure Medical Ltd.

N/A

Current Price

$0.67

Market Cap

43.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
POAS
ICCM
Founded
2017
2006
Country
Singapore
Israel
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
23.6M
43.4M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
POAS
ICCM
Price
$1.69
$0.67
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$2.50
AVG Volume (30 Days)
1.6M
136.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$19.87
Revenue Next Year
N/A
$31.38
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$0.54
52 Week High
$7.40
$1.53

Technical Indicators

Market Signals
Indicator
POAS
ICCM
Relative Strength Index (RSI) 41.66 58.32
Support Level $0.53 $0.58
Resistance Level $2.27 $0.74
Average True Range (ATR) 0.27 0.04
MACD 0.06 0.01
Stochastic Oscillator 57.86 67.81

Price Performance

Historical Comparison
POAS
ICCM

About POAS Phaos Technology Holdings (Cayman) Limited Class A Ordinary Shares

Phaos Technology Holdings Cayman Ltd is an investment holding company incorporated in the Cayman Islands. Through its subsidiaries, the Company engages in the research, development, manufacturing, and commercialization of advanced optical technologies and products. Leveraging its patented microsphere technology, Phaos enhances the magnification of traditional optical microscopes, enabling visualization beyond the 200nm optical limit at a commercially viable working distance. The Company offers advanced microscopy equipment and parts, along with AI-powered software solutions that complement its hardware to deliver fully integrated microscopy systems. Its technologies serve diverse sectors, including manufacturing, biomedical, and research.

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: